RIPK3 knockdown improved metabolic syndrome and hepatic steatosis in HFD‐fed mice via the TLR−4/NF‐κB and Nrf2/HO−1 signalling pathways. The gene discussed is NFKB1; the disease is Hepatic steatosis.